Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Dicker

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Cell Cycle (Georgetown, Tex.)|June 2, 2015
ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cellsMala K Talekar, Joshua E Allen, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell linesRaluca T Tavaluc, Lori S Hart, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|May 10, 2017
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxiaJun Zhang, Lanlan Zhou, Shuai Zhao, et al.
Cancer Research|February 26, 2015
Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent MannerVarun V Prabhu, Joshua E Allen, David T Dicker, et al.
Cancer Biology & Therapy|July 26, 2011
Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interactionLanLan Zhou, Wenge Wang, David T Dicker, et al.
Cancer Biology & Therapy|July 20, 2011
Hyperspectral imaging: a non-invasive method of imaging melanoma lesions in a patient with stage IV melanoma, being treated with a RAF inhibitorDavid T Dicker, Nadia Kahn, Keith T Flaherty, et al.
F1000Research|September 5, 2017
Circulating tumor cells: silent predictors of metastasisLanLan Zhou, David T Dicker, Elizabeth Matthew, et al.
Molecular and Cellular Biology|August 5, 2003
Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cellsTimothy F Burns, Peiwen Fei, Kimberly A Scata, et al.
Cell Cycle (Georgetown, Tex.)|November 14, 2002
The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression)Joanna K Sax, Bipin C Dash, Rui Hong, et al.
Cell Cycle (Georgetown, Tex.)|November 6, 2013
CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growthNoel A Warfel, Nathan G Dolloff, David T Dicker, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Cell Cycle (Georgetown, Tex.)|June 2, 2015
ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cellsMala K Talekar, Joshua E Allen, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell linesRaluca T Tavaluc, Lori S Hart, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|May 10, 2017
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxiaJun Zhang, Lanlan Zhou, Shuai Zhao, et al.
Cancer Research|February 26, 2015
Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent MannerVarun V Prabhu, Joshua E Allen, David T Dicker, et al.
Cancer Biology & Therapy|July 26, 2011
Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interactionLanLan Zhou, Wenge Wang, David T Dicker, et al.
Cancer Biology & Therapy|July 20, 2011
Hyperspectral imaging: a non-invasive method of imaging melanoma lesions in a patient with stage IV melanoma, being treated with a RAF inhibitorDavid T Dicker, Nadia Kahn, Keith T Flaherty, et al.
F1000Research|September 5, 2017
Circulating tumor cells: silent predictors of metastasisLanLan Zhou, David T Dicker, Elizabeth Matthew, et al.
Molecular and Cellular Biology|August 5, 2003
Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cellsTimothy F Burns, Peiwen Fei, Kimberly A Scata, et al.
Cell Cycle (Georgetown, Tex.)|November 14, 2002
The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression)Joanna K Sax, Bipin C Dash, Rui Hong, et al.
Cell Cycle (Georgetown, Tex.)|November 6, 2013
CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growthNoel A Warfel, Nathan G Dolloff, David T Dicker, et al.
Pageof 10